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Abstract 
Background: 1,2,4-Triazole3-thiones are good scaffolds for preparation of new lead compounds. Their derivatives 
attracted the attention of chemists due to their wide spectrum of biological activities. Alkylsulfanyl-1,2,4-triazoles have 
three nucleophilic sites (nitrogens) ready for reaction with electrophiles. Herein, new regioselective isomers were syn-
thesized by the reaction of benzylsulfanyl-1,2,4-triazole with various dihaloalkanes. Regioselectivity was determined 
by X-ray crystallography and NMR.
Results: Coupling of 3-benzylsufanyl-5-(1H-indolyl)-1,2,4-triazole with dibromomethane, 1,2-dichloroethane, 
1,3-dibromopropane and di(bromomethyl)quinoxaline was investigated in the presence of potassium carbonate in 




2-6) were formed in which the two bromide atoms were replaced by two triazole moieties. Among these 
isomers the reaction was regioselective towards the –N1–CH2–N
2-5 isomer due to the steric effect. In the case of 
1,3-dibromopropane two compounds were obtained due to the alkylation at N(2) to give 2-(3-bromopropyl)-triazole 
8 and alkylation at N(1) was followed by cyclization at the indole nitrogen to form a condensed indolo-triazolo-
diazepine 10. Upon alkylation of 3-benzylsufanyl-5-(1H-indolyl)-1,2,4-triazole with di(bromomethyl)quinoxaline, two 
bis(triazolyl-methyl)quinoxaline isomers were separated and characterized as (–N1–CH2–N
1–) 11 and (–N2–CH2–N
2–) 
12. Single-crystal X-ray diffraction assisted the elucidation and confirmation of the structures of the isomers. An AM1 
theoretical study explained the regioselectivity of the alkylation.
Conclusions: On reacting S-protected 1,2,4-triazoles with various alkylating agents, only N(1) and N(2) attack the 
electrophilic carbons. N(2) alkylated isomers are preferentially formed.
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Background
After designing and applying a synthetic approach, struc-
ture elucidation and confirmation constitutes the second 
important step. Sometimes, spectroscopic techniques are 
not enough for structure confirmation, especially when 
the starting scaffolds have more than one site accessible 
to the reaction such as dihydro-1,2,4-triazole-thione I 
and S-protected 1,2,4-triazole II (Fig.  1). Here, the dif-
ficulty arises in assigning which nitrogen atom will be 
alkylated.
Most of published literature concentrated their stud-
ies on preparation of the parent triazoles I and the cor-
responding S-substituted analogs II. The reasons for this 
may be the high yields of the S-derivatives, and lack of 
interest to assign which nitrogen had reacted due to the 
extra effort needed for separation and structure determi-
nation. Nevertheless, the triazoles of type I and II were 
subjected to many biological investigations and showed 
a wide range of activities such as antimicrobial [1–3], 
antituberculosis [4], antiviral [5, 6], anti-inflammatory [7, 
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8], anticonvulsant [9] and antiproliferative [10] proper-
ties. Moreover, selective inhibition activities for COX-2 
[11], urease [12] and trans-cinnamate 4-hydroxylase [13] 
were found. Some structures of the alkylsulfanyl-1,2,4-
triazoles II were confirmed by single-crystal X-ray dif-
fraction [14–16].
Structural reports dealing with the alkylation at nitro-
gen atoms of S-protected 1,2,4-triazoles with mono alkyl 
halides are very limited [17–19]. Despite the huge effort 
that has been done using NMR spectroscopy for deter-
mination of regioselectivity, conflicts in assignment of 
the alkylation site are found. For example, alkylation was 
proposed to include (S-, 2-N-) and (S-, 4-N-) in [17, 18], 
(S-, 2-N-) and (S-, 1-N-) was suggested in [3] but (S-, 
1-N-) only was shown in [19]. Substitution at the sulfur 
followed by cyclization at nitrogen (2-N-) was proposed 
in [20, 21] whereas at nitrogen (4-N-) was found in [22]. 
Hence, the published assignments of the alkylation pat-
tern in 1,2,4-triazoles seem unclear.
Hence, the present study is the first research work 
concerned with determination of the regioselectiv-
ity of alkylation upon reacting dihaloalkanes with an 
S-alkylated 1,2,4-triazole. Growing of single crystals of 
the products permitted elucidation of the alkylation site 
and supported the structure assignment of the remaining 
isomers by NMR.
Results and discussion
Dihydro-1,2,4-triazolinethione 1 was coupled with 
(dibromomethyl)quinoxaline in the presence of K2CO3 
and benzyl bromide using pyridine to afford the 
required S-protected 1,2,4-triazoles 2 and 3, respectively 
(Scheme 1).
Dibromomethane as the shortest-chain alkylation rea-
gent was first reacted with 3-benzylsulfanyl-5-(1H-indol-
2-yl)-2H-1,2,4-triazole 3 in the presence of K2CO3 as an 
acid scavenger. Three isomers 4–6 were separated by col-
umn chromatography in 15, 50 and 10 % yields, respec-
tively. Increasing the length of the carbon chain and 
reacting 3 with dichloroethane led to the replacement 
of one chlorine atom by the triazolyl moiety to give 7. 
However, the use of 1,3-dibromopropane under the same 
conditions yielded 8 and 10 and the reaction was more 
selective towards 8 which formed in 60 % yield compared 
to 10 which formed in 28 % yield (Scheme 2).
Reaction of S-benzylated triazole 3 with (dibromo-
methyl)quinoxaline afforded two bis(triazolylmethyl) 
quinoxaline isomers 11 and 12 and no cyclization was 
observed (Scheme 3).
Structure confirmation (Additional files 1 and 2)
The 1H NMR of 2 showed a singlet signal at 5.04 ppm for 
the two SCH2 groups and the protons of the indole and 
the quinoxaline appeared between 6.95 and 8.01  ppm. 
Two broad signals appeared at 11.70 and 14.43  ppm 
which are characteristic for indole and triazole NHs. 
13C NMR showed the two benzyl methylene carbons (2 
SCH2) at 36.16  ppm. The quinoxaline (CH) carbon sig-
nals appeared at 128.3 and 130.27 ppm, whereas its qua-
ternary carbons appeared at 140.25 and 151.39 ppm. The 
1H NMR of 3 shows two D2O exchangeable signals at 
11.77 for the indole NH and 14.37  ppm for the triazole 
NH. The benzyl methylene protons appeared as singlet 
at 4.45  ppm and the corresponding methylene carbon 
appeared in 13C NMR at 35.66  ppm. The presence of a 
signal around 14.40 ppm in 1H NMR of 2 and 3 confirms 
that only one proton has been replaced. The absence of a 
thiocarbonyl (C = S) signal around 166.6 ppm [3] in the 
13C NMR of 2 and 3 strongly recommends the alkylation 
of sulfur.
The NH signal at 14.37 ppm (in the spectrum of 3) dis-
appeared in the 1H NMR spectra of compounds 4–12 
which means that this proton has been substituted. The 
1H NMR of 4 showed the four methylene protons of the 
two benzyl groups at 4.30  ppm, the two protons of the 
methylene bridge connecting the two triazolyl moieties at 
6.92  ppm and the indole NH proton at 12.01  ppm. The 
13C NMR showed the two benzyl methylene carbons at 
34.8  ppm while the methylene carbon connecting the 
two triazole moieties appeared at 60.0 ppm. The two tria-
zole carbons (C-5Triazol, C-3Triazol) appeared at 150.60 and 
160.04 ppm respectively.
The 1H NMR spectrum of 5 showed two signals for the 
four methylene protons of the two benzyl groups at 4.31 
and 4.60  ppm while the two protons of the methylene 
bridge connecting the two triazole moieties appeared at 
6.64 ppm. The NH protons of the two indole rings were 
found at 11.64 and 11.95  ppm. The 13C NMR displayed 
the two methylene carbons of the two benzyl groups at 
34.8 and 37.4  ppm, whereas the methylene bridge car-
bon was found at 59.2 ppm. The four carbons of the two 
triazole rings were identified at 150.3, 154.3, 156.7 and 
159.96, respectively.














Fig. 1 Structure of dihydro-1,2,4-triazole-thione I and S-protected 
1,2,4-triazole II
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The 1H NMR of 6 showed one signal of the benzyl meth-
ylene protons at 4.57 ppm and methylene carbon bridge 
(connecting the two triazole moieties) at 6.32 ppm. The 
NH of the two indole rings appeared at 11.61 ppm. The 
13C NMR showed the two methylene carbons of the two 
benzyl groups at 37.5  ppm while the methylene carbon 
bridge appeared at 58.7  ppm. The triazole carbons are 
assigned to the signals at 153.6 (for C-3) and 156.7 ppm 
(for C-5). The above facts showed that in the case of 5 a 
distinct signal appeared for each benzyl methylene group 
assuming that this isomer is asymmetric in liquid NMR. 
However, the NMR of the isomers 4 and 6 showed only 
one signal representing the two benzyl methylene groups 
which suggests symmetric molecules. The HMBC sche-
matic representation (Scheme 2) shows the coupling cor-
relations of the methylene protons (benzyl and bridge) 
and the triazole carbons in the three isomers 4-6. The 
HMBC spectrum of 4 showed a 3JC,H coupling correla-
tion between the benzyl methylene protons at 4.30 ppm 
and the triazole carbon at 160.0 ppm, while the connect-
ing methylene protons at 6.92 ppm showed 3JC,H coupling 
with the triazole carbon at 150.6 ppm. In the HMBC of 
isomer 6, both benzyl methylene protons at 4.57 ppm and 
the connecting methylene protons at 6.32 ppm displayed 
a coupling correlations 3JC,H to the same triazole carbon 
at 153.6 ppm. In the HMBC of the isomer 5 the situation 
is different, because there are four signals of the triazole 
carbons and two signals of the methylene groups of the 
two benzyls. As a result, the benzyl methylene protons at 
4.31 ppm showed 3JC,H coupling to the triazole carbon at 
160.0 ppm, whereas the other benzyl methylene protons 
at 4.60  ppm displayed the correlation 3JC,H to a triazole 
carbon at 156.8 ppm. The connecting methylene protons 
at 6.64 ppm showed a 3JC,H correlation to the two triazole 
carbons at 150.3 and 154.3 ppm. The structures of 4 and 
6 were further confirmed by single crystal X-ray diffrac-
tion analysis as shown in Figs. 2, 3.
The 1H NMR spectrum of 7 showed three methylene 
groups (-NCH2CH2Cl and -SCH2Ph) at 3.74, 4.25 and 
4.44  ppm. The three related methylene carbons were 
detected in 13C NMR at 38.9, 41.4 and 49.8 ppm. The two 
triazole carbons appeared at 152.8 and 157.1 ppm. The EI 
mass spectrum showed the molecular ion peak at 368.0 
(80.2) and 370.0 (31.9) for (M + 2)+, indicating the pres-
ence of chlorine.
The 1H NMR of 8 displayed four methylene group 
signals at 2.48, 3.74, 4.42 and 4.81  ppm. The 13C NMR 
showed the respective four methylene carbons at 31.0, 
31.9, 37.4 and 46.6 ppm and the two triazole carbons at 
151.4 and 156.2  ppm. The mass spectrum (ESI) showed 
two peaks at m/z 427 (98.2  %) for (M  +  H)+ and 429 
(100 %) for (M + H+2)+ which strongly recommend the 
presence of the bromine atom.
The spectra of 10 showed three signals at 2.43–2.48, 
4.39, and 4.52–4.54  ppm for the four methylene groups 
whereas the related methylene carbons appeared at 25.2, 
35.0, 44.7 and 51.7 ppm. The chemical shifts of 44.7 and 
51.7 ppm indicate that there are two methylene carbons 
attached to two different nitrogen atoms (triazole and 
indole). The two triazole carbon signals were found at 
148.6 and 158.5  ppm. This indicates that one bromine 
atom of 1,3-dibromopropane is removed first due to the 
attack of the triazole nitrogen and due to a proximity 




































Scheme 1 S-alkylation of 1,2,4-triazolethione 1




























































































Scheme 2 Products obtained from reaction of 3 with dibromomethane, 1,2-dichloroethane and 1,3-dibromopropane. HMBC schematic represen-
tation of different bis-(triazolyl)methane isomers
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is then lost upon the attachment of the methylene carbon 
to the nitrogen of the indole. The structures of 8 and 10 
were further confirmed by X-ray single crystal structures 
(Figs. 4, 5, Additional file 1).
The 1H NMR spectrum of 11 displayed the methylene 
protons of the benzyl group as singlet at 4.34 ppm while 
the methylene protons attaching triazole and quinoxaline 
rings appeared as a singlet at 6.14  ppm. The respective 
methylene carbons appeared at 36.44 and 51.97 ppm. All 
aromatic protons appeared between 6.90 and 8.20  ppm 
and the indole NH appeared at 10.56 ppm. The triazole 
carbons appeared at 149.05 and 160.33 ppm.
The 1H NMR spectrum of 12 showed the indole NH 
signal at 11.60 ppm. The methylene protons of the benzyl 
group were found at 5.22 ppm while the methylene pro-
tons linking triazole and quinoxaline rings appeared at 
5.42 ppm. The respective methylene carbons were found 
at 37.9 and 52.3  ppm, respectively. Moreover, the two 
carbon signals of the triazole carbons appeared at 152.4 
and 156.8 ppm.
X‑ray analysis
Single-crystal X-ray diffraction analysis afforded unambig-
uous structural assignments of the isomers formed. All sin-
gle crystals were grown by slow evaporation of the eluent 
(ethyl acetate/hexane 2:8). Crystal data showed that crystals 
of 4 and 6 have the same empirical formula and formula 
weight. Compound 6 crystallizes in the C2/c space group 
with Z = 4, which means that the molecules of 6 occupy 
special positions. Atom C18 is located at a twofold proper 
rotation axis. This means that in the case of 6 the molecular 
conformation in liquid (NMR) and in the solid state is the 
same. On the other hand, in the case of 4 the space group 
is P21/c, Z  =  4, which means that the molecules occupy 
general positions and hence can be asymmetric. In liquid 
(NMR) they appear symmetric which indicates that the 
molecular conformation is a soft molecular parameter and 
the crystal lattice arrangement changes it. The crystallo-
graphic data of the isomers 4 and 6 are shown in Table 1.
2-(3-Bromopropyl)-triazole 8 crystallized in the mono-







































Scheme 3 Reaction of S-benzyl-1,2,4-triazole with dibromomethylquinoxaline
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10 crystallized as triclinic space group P-1. The crystallo-
graphic data of compounds 8 and 10 are given in Table 2.
In General, all crystalline compounds 4, 6, 8 and 10 are 
nonplanar. This is because the benzyl groups are almost 
perpendicularly positioned to the plane of indolyltriazole 
system (Tables 3, 4). In crystals of 6, 8 and 10 the indole 
and triazole rings are located nearly in the same plane 
(torsion angles are around 10°), except in one half of iso-
mer 4 in which the two intramolecular hydrogen bonds 
N(8)–H(8  N)…N(4) and C(6)–H(6a)…N(4) appeared in 
the mono-structure (Fig.  1) twisted the indole ring and 
deviated this planarity by making torsion angles N(7)–
C(20)–C(21)–N(8) of 148.37° and at N(7)–C(20)–C(21)–
C(24) of 31.1°, respectively (Tables 3).
In crystal 10, the diazepine ring is not planar because 
torsion angles at N(2)–C(10)–C(11)–C(12) of torsion 
angles at and at C(10)–C(11)–C(12)–N(1) of 76.44° 
appeared.
The supramolecular structures are stabilized in the 3D 
network by the intermolecular hydrogen bonding and 
van der Waals interactions (Figs. 6, 7, 8, 9). Both, 8 and 
10 are centrosymmetric and no isomers are present due 
to the absence of a stereo center.
AM1 computational analysis of bis(triazolyl)methane 
isomers
The calculated empirical data of the three isomers 
4–6 shows that isomer 5 has the lowest steric energy 
16.2704  kcal/mol. This suggests that it will be formed 
with the highest yield with respect to the remaining 
two isomers 4 and 6. This is in well agreement with the 
yields found in the synthesis of 5, 4, and 6 (being 50, 15 
and 10  %, respectively). Moreover, we found that the 
Fig. 2 Ortep representation showing the N(2) attack in (bistriazolyl)methane 4 in addition to the effect of two intramolecular hydrogen bonds on 
the planarity of one indolyltriazole
Fig. 3 Ortep representation showing the N(1) attack in (bistriazolyl)
methane 6
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charge density on the triazole nitrogens is mainly delo-
calized on N(1) and N(2). Accordingly, if the negative 
charge is located on N(1) or N(2), they will be preferen-
tially attack the electrophilic carbon (Table 5) in alkyla-
tion reactions.
Conclusion
Upon alkylation of S-substituted 1,2,4-triazoles with dih-
aloalkanes, products will appear preferentially resulting 
from the attack of the alkyl moiety at N(1) or N(2) of the 
triazole. Theoretical calculations reveal that there is no 
chance to obtain an alkylation on N(4) due to the steric 
energy. This is also concluded from HMBC and 13C NMR 
which additionally help in the structure assignment of 
the positions of the two carbon atoms of the alkylated 
triazole. If they appear around 152.0 and 157.0 ppm sub-
stitution at the nitrogen atom nearest to sulfur, i.e. N(2), 
can be deduced. However, a substitution on the nitro-
gen atom far from sulfur, i.e. N(1), can be derived if the 
carbon atoms of the alkylated triazole appear around 
149.0 ppm and 160.0 ppm. These results were confirmed 
by single-crystal X-ray diffraction.
Fig. 4 Ortep representation of 8 showing the attachment of 3-bromopropyl to N(2)
Fig. 5 Ortep representation of indolo-triazolo-diazepine 10
Page 8 of 13Boraei et al. Chemistry Central Journal  (2016) 10:22 
Experimental
Melting points were determined with a melting-tem-
perature apparatus (SMP10) in open capillaries and are 
uncorrected. The progress of all reactions was monitored 
by TLC pre-coated plates with silica gel 60 F254 of a thick-
ness of 0.25  mm (Merck). Detection was achieved by 
UV light absorption and/or treatment with a solution of 
10 % H2SO4 in aqueous methanol with subsequent heat-
ing. For flash chromatography commercial silica gel 60 
was used with particle sizes 0.040–0.063  mm (230–400 
mesh ASTM). Solvents were purified by simple distilla-
tion. Nuclear magnetic resonance (1H NMR, 13C NMR 
and 2D NMR) spectra were determined in CDCl3 and 
DMSO-d6 and were recorded on Bruker AC 300–600 
spectrometers, with tetramethylsilane as internal stand-
ard. Chemical shifts are reported in δ (ppm) and coupling 
constants are given in Hz. The assignment of exchange-
able OH and NH was confirmed by addition of D2O. EI 







Formula weight 624.77 624.77
Colour Colourless Colourless
Shape Plate Rod
Max size/mm 0.31 0.35
Mid size/mm 0.18 0.05
Min size/mm 0.02 0.04
T/K 123.0 123.0
Crystal system Monoclinic Monoclinic
Space group P21/c C2/c
a/Å 14.8390 (2) 32.9005 (5)
b/Å 11.33640 (10) 8.04840 (12)
c/Å 17.8545 (2) 11.51861 (19)
α/° 90 90
β/° 102.2920 (10) 106.0192 (17)
γ/° 90 90







Measured Refl. 23347 10434
Independent Refl. 5819 2927




Largest peak 0.871 0.285
Deepest hole −0.460 −0.194
GooF 1.049 1.033
wR2 (all data) 0.1058 0.0852
wR2 0.1015 0.0841
R1 (all data) 0.0428 0.0328
R1 0.0388 0.0317
CCDC 1,420,937 1,420,938







Formula weight 427.36 346.44
Colour Translucent colourless Colourless
Shape Rod Stick
Max size/mm 0.52 0.51
Mid size/mm 0.10 0.14
Min size/mm 0.04 0.07
T/K 123 123.0
Crystal system Monoclinic Triclinic
Space group P21/c P-1
a/Å 9.13384 (13) 9.0486 (4)
b/Å 21.7680 (3) 9.1081 (5)
c/Å 9.47711 (13) 11.7993 (6)
α/° 90 68.513 (5)
β/° 93.8246 (13) 80.348 (4)
γ/° 90 64.771 (5)







Measured Refl. 6987 5423
Independent Refl. 3533 3154




Largest peak 0.350 0.278
Deepest hole −0.464 −0.279
GooF 1.072 1.046
wR2 (all data) 0.0802 0.0840
wR2 0.0776 0.0822
R1 (all data) 0.0356 0.0340
R1 0.0293 0.0320
CCDC 1420939 1420940
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mass spectra were recorded with a Finnigan MAT312 
and a Jeol JMS.600H mass spectrometer. HREI mass 
spectral data were recorded with a Finnigan MAT 95XP 
instrument. FABMS was recorded with the Jeol JMS 
HX110 mass spectrometer. ESI were recorded with an 
Applied Biosystems QStar XL instrument. The crystal-
lographic measurements were performed on an Agilent 
(formerly Oxford diffraction) SuperNova Atlas CCD dif-
fractometer. The structures were solved by direct meth-
ods (SIR97) and refined by full-matrix anisotropic least 
squares (SHELXL-2014/7).
Synthesis of S‑alkylated derivatives (2, 3)
To a mixture of traizole 1 (1.0 mmol) in acetone (10 ml) 
and appropriate base (4.0  mmol), 2,3-bis(bromomethyl)
quinoxaline (0.5  mmol) or benzyl bromide (1.1  mmol) 
were added and stirring was continued overnight. The 
reaction mixture was filtered. The solvent was evaporated 
in vacuo and cold water was added. The solids formed 
were collected by filtration, dried, and separated by col-
umn chromatography (ethyl acetate/hexane 1:1) 2 or 
crystallization from ethanol 3.
2,3‑Bis((5‑(1H‑indol‑2‑yl)‑2H‑1,2,4‑triazol‑3‑ylsulfanyl)
methyl)quinoxaline (2)
White solid, Yield 71 %; m.p. 203decomp.  °C; Rf 0.35 (ethyl 
acetate/n-hexane 6:4); 1H NMR (DMSO-d6, 300 MHz) δ 
5.04 (s, 4 H, 2 CH2), 6.95 (s, 2 H, 2 H-3Indol), 7.00 (dd, 2 
H, J4,5 ≈ J5,6 7.5, Hz, 2 H-5Indol), 7.13 (dd, 2 H, J5,6 7.5, J6,7 
8.1  Hz, 2 H-6Indol), 7.41 (d, 2 H, J6,7 8.1  Hz, 2 H-7Indol), 
7.56 (d, 2 H, J4,5 7.5  Hz, 2 H-4Indol), 7.78–7.82 (m, 2 H, 
2 CHquinoxalin), 7.97–8.01 (m, 2 H, 2 CHquinoxalin), 11.70 
(br. s, 2 H, NHIndol), 14.43 (br. s, 2 H, NHTriazol); 13C NMR 
(DMSO-d6, 100 MHz) δ 36.16 (2 CH2), 101.70 (2 C-3Indol), 
111.99 (2 C-7Indol), 119.72 (2 C-5Indol), 120.74 (2 C-4Indol), 
122.70 (2 C-2Indol, 2 C-6Indol), 127.2 (2 C-3aIndol), 128.30 
(2 CHquinoxalin), 130.27 (2 CHquinoxalin), 136.91 (2 C-7aIn-
dol, 2 C-5Triazol, 2 C-3Triazol), 140.25 (2 Cquinoxalin), 151.39 
(2 Cquinoxalin); HRMS (FAB +ve) calcd for C30H23N10S2 
M + H)+: 587.15486. Found: 587.1508.
3‑Benzylsulfanyl‑5‑(1H‑indol‑2‑yl)‑2H‑1,2,4‑triazole (3)
Yield 97  %; m.p. 219–220  °C; Rf 0.49 (ethyl acetate/n-
hexane 4:6); 1H NMR (DMSO-d6, 300  MHz) δ 4.45 (s, 
2 H, CH2Ph), 6.99–7.05 (m, 2H, H-3Indol, H-5Indol), 7.15 
(dd, 1H, J5,6 7.3, J6,7 7.7 Hz, H-6Indol), 7.21–7.45 (m, 6 H, 
H-7Indol, 5HPh), 7.59 (d, 1 H, J4,5 7.9  Hz, H-4Indol), 11.77 
(br. s, 1H, NHIndol), 14.37 (br. s, H, NHTriazol); 13C NMR 
(DMSO-d6, 75 MHz) δ 35.66 (CH2Ph), 100.99 (C-3Indol), 
111.94 (C-7Indol), 119.67 (C-5Indol), 120.66, 122.60, 127.27, 
127.67 (C-2Indol, C-4Indol, C-6Indol, CHPh, C-3aIndol), 128.42 
(2 CHPh), 128.83 (2 CHPh), 136.84, 137.64 (C-7aIndol, 
C-3Triazol, C-5Triazol, CPh); HRMS (EI) calcd for C17H14N4S 
(M+.): 306.0939. Found: 306.0886.
Alkylation of S‑benzylated triazole 3
To a mixture of traizole 3 (1.0 mmol) in acetone (10 ml) 
and K2CO3 (2.1  mmol), appropriate dihaloalkane 
Table 3 Selected torsion angles and hydrogen bonding in crystals of 4 and 6
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compound (0.5 mmol) was added and stirring was con-
tinued overnight. The reaction mixture was filtered and 
dried. Then, the products were separated by column 
chromatography (ethyl acetate/hexane 0.5:9.5).
Bis(3‑benzylsulfanyl‑5‑(1H‑indol‑2‑yl)‑1H ‑1,2,4‑triazol‑1‑yl)
methane (4)
Colorless needle crystals; Yield 15  %; m.p. 218–219  °C; 
Rf 0.73 (ethyl acetate/n-hexane 4:6); 1H NMR (DMSO-
d6, 300 MHz) δ 4.30 (s, 4H, 2 SCH2Ph), 6.92 (s, 2H, CH2), 
7.08 (dd, 2H, J4,5 = 7.9, J5,6 = 7.3 Hz, H-5Indol), 7.16–7.30 
(m, 12H, H-6Indol, 10 HPh), 7.48–7.51 (m, 4H, H-3Indol, 
H-7Indol), 7.62–7.65 (d, 1H, J4,5 = 7.9 Hz, H-4Indol), 12.01 
(br. s, 2H, NHIndol); 13C NMR (DMSO-d6, 75 MHz) δ 34.8 
(2 SCH2Ph), 60.0 (CH2), 104.8 (C-3Indol), 112.2 (C-7Indol), 
120.1 (C-5Indol), 121.3 (C-4Indol), 123.1 (C-2Indol), 123.7 
(C-6Indol), 127.2 (CHPh), 127.6 (C-3aIndol, CPh), 128.3 (2 
CHPh), 128.9 (2 CHPh), 137.1, 137.7 (C-7aIndol, CPh), 150.6 
(C-5Triazol), 160.04 (C-3Triazol); HRMS (ESI) calcd for 
C35H29N8S2 (M + H)+: 625.1951. Found: 625.1900.
1,2‑Bis(3‑benzylsulfanyl‑5‑(1H‑indol‑2‑yl)‑1H‑1,2,4‑tria‑
zol‑1‑yl)methane (5)
Colorless crystals; Yield 50  %; m.p. 214-215  °C; Rf 0.71 
(ethyl acetate/n-hexane 4:6); 1H NMR (DMSO-d6, 
300  MHz) δ 4.31 (s, 2H, CH2), 4.60 (s, 2H, CH2), 6.64 
(s, 2H, CH2), 6.98–7.03 (m, 2H, H-3Indol, H-5Indol), 7.09–
7.19 (m, 5H, H-6Indol, H-5Índol, 3HPh), 7.23–7.33 (m, 6H, 
H-6́Indol, 5HPh), 7.40–7.51 (m, 5H, H-3Índol, H-7Indol, 
H-7Índol, 2HPh), 7.57 (d, 1H, J4,5 = 7.8 Hz, H-4Indol), 7.73 
(d, 1H, J4́,5 ́= 7.9 Hz, H-4́Indol), 11.65 (br. s, 1H, NHIndol), 
11.95 (br. s, 1H, NHÍndol); 13C NMR (DMSO-d6, 75 MHz) 
δ 34.8 (SCH2Ph), 37.4 (SCH2Ph), 59.2 (CH2), 101.5 
(C-3Indol), 104.9 (C-3́Indol), 111.9, 112.1 (C-7Indol, C-7́Indol), 
119.6 (C-5Indol), 120.1, 120.6, 121.4, 122.5, 123.1 (C-4Indol, 
C-4Índol, C-5́Indol, C-6Indol, C-6́Indol), (C-2Indol,), 127.1, 127.6 
(CPh, ĆPh), 127.7, 128.2, 128.3, 128.5, 128.9, 130 (C-3aIndol, 
2 CHPh, C-3áIndol, 2 CHPh, 2 CHPh,́ 2 CHPh)́, 136.9, 137.0, 
137.1, 137.7 (C-7aIndol, C-7áIndol, CPh, CPh)́, 150.3, 154.3, 
156.7, 159.96 (C-3Triazol, C-3ʹTriazol, C-5Triazol, C-5́Triazol); 




Colorless sunny crystals; Yield 10 %; m.p. 249–250 °C; Rf 
0.65 (ethyl acetate/n-hexane 4:6); 1H NMR (DMSO-d6, 
300 MHz) δ 4.57 (s, 4H, 2 SCH2Ph), 6.32 (s, 2H, CH2), 6.94 
(s, 2H, 2H-3Indol), 7.18 (dd, 2H, J4,5 =  7.8, J5,6 =  7.5 Hz, 
2H-5Indol), 7.12 (dd, 2H, J5,6 = 7.5, J6,7 > 8.0 Hz, 2H-6Indol), 
Table 4 Selected torsion angles and hydrogen bonding in crystals of 8 and 10
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7.23–7.32 (m, 6H, 6Hph), 7.41–7.46 (m, 6H, 2H-7Indol, 
4HPh), 7.56 (d, 1H, J4,5 = 7.8 Hz, 2H-4Indol), 11.61 (br. s, 
2H, NHIndol); 13C NMR (DMSO-d6, 100 MHz) δ 37.5 (2 
SCH2Ph), 58.7 (CH2), 101.4 (2C-3Indol), 112.0 (2C-7Indol), 
119.6 (2C-5Indol), 120.6 (2C-2Indol, 2C-4Indol), 122.5 
(C-6Indol), 127.65 (2CHPh), 127.7, 128.3 (2C-3aIndol, 2CPh), 
128.5 (4 CHPh), 129.08 (4 CHPh), 136.75, 137.0 (2C-7aIn-
dol, 2CPh), 153.6 (2C-3Triazol), 156.7 (2C-5Triazol); HRMS 




Colorless crystals, Yield 55  %; m.p. 126–127  °C; Rf 
0.80 (ethyl acetate/n-hexane 6:4); 1H NMR (CDCL3, 
400 MHz) δ 3.74 (t, 2 H, J 6.4 Hz, CH2Cl), 4.25 (t, 2 H, 
J 6.4  Hz, NCH2), 4.44 (s, 2 H, SCH2Ph), 7.10–7.14 (m, 
2 H, H-3Indol, H-5Indol), 7.23 (dd, 1 H, J5,6 6.8, J6,7 8.4 Hz, 
H-6Indol), 7.27–7.29 (m, 5 H, Ph), 7.39 (d, 1 H, J6,7 8.0 Hz, 
H-7Indol), 7.67 (d, 1 H, J4,5 8.0 Hz, H-4Indol), 9.06 (br. s, 1H, 
NHIndol); 13C NMR (CDCl3, 100 MHz) δ 38.95 (SCH2Ph), 
41.38 (CH2Cl), 49.81 (NCH2), 101.90 (C-3Indol), 111.18 
(C-7Indol), 120.31 (C-5Indol), 121.34 (C-4Indol), 123.21 
(C-2Indol, C-6Indol), 127.94 (CHPh), 128.68 (C-3aIndol), 
128.80, 128.93 (4 CHPh), 136.36, 136.56 (C-7aIndol, CPh), 
152.76 (C-5Triazol), 157.07 (C-2Triazol); LRMS-EI m/z (%): 
65 (11.7), 91 (100), 115 (12.6), 142 (80.1), 143 (12.9), 241 
(11.8), 242 (30.3), 332 (16.1), 333 (41.4), 368 (80.2), 370 
(31.9); HRMS (EI) calcd for C19H17N4SCl (M): 368.0862 
(80.2 %). Found: 368.0857, M + 2: 370.0 (31.9).
3‑Benzylsulfanyl‑2‑(3‑bromopropyl)‑5‑(1H‑indol‑2‑yl) 
‑1,2,4‑triazole (8)
Colorless crystals, Yield 60 %; m.p. 96–97 °C; Rf 0.66 (ethyl 
acetate/n-hexane 4:6); 1H NMR (DMSO-d6, 600 MHz) δ 
2.48–2.50 (m, 2H, CH2), 3.74 (t, 2H, J  =  5.4  Hz, CH2), 
4.42 (t, 2H, J =  6.6 Hz, CH2), 4.81 (s, 2H, CH2Ph), 7.22 
(s, 1H, H-3Indol), 7.30 (dd, 1H, J4,5  =  7.8, J5,6  =  7.2  Hz, 
H-5Indol), 7.42 (dd, 1H, J5,6 = 7.2, J6,7 = 8.4 Hz, H-5Indol), 
7.54–7.87 (m, 7H, H-4Indol, H-7Indol, 5HPh), 11.91 (s, 1H, 
NHIndol); 13C NMR (DMSO-d6, 150 MHz) δ 31.0 (CH2), 
Fig. 6 Packing diagram of 4. Dashed lines represent hydrogen bonds
Fig. 7 Packing of the molecules in the unit cell of 6. Dashed lines 
represent hydrogen bonds
Fig. 8 Packing diagram of 8. Dashed lines represent hydrogen bonds
Fig. 9 Packing diagram of 10. Dashed lines represent hydrogen 
bonds
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31.9 (CH2), 37.4 (CH2Ph), 46.6 (NCH2), 100.6 (C-3Indol), 
111.8 (C-7Indol), 119.5 (C-5Indol), 120.5 (C-4Indol), 122.2 
(C-6Indol), 127.6, 127.8, 128.5, 128.6, 128.7, 128.9, 129.1, 
128.2, 136.8, 137.2 (C-2Indol, C-3aIndol, 5CHPh, C-7aIndol, 
CPh), 151.4 (C-5Triazol), 156.2 (C-3Triazol); HRMS (ESI) 
calcd for C20H20BrN4S (M  +  H)+: 427.0592 Found: 
427.0585 (M + H)+, 429 (100 %) for (M + H+2)+.
1H‑Indolo[1,2‑a]‑3‑phenylsul‑
fanyl‑1,2,4‑triazolo[1,5‑c]1,4‑diazepine (10)
Colorless crystals, Yield 28  %; m.p. 148–149  °C; Rf 0.35 
(ethyl acetate/n-hexane 4:6); 1H NMR (DMSO-d6, 
600 MHz) δ 2.43–2.48 (m, 2H, CH2), 4.39 (s, 2H, CH2Ph), 
4.45–4.54 (m, 4H, 2 CH2), 7.12 (dd, 1H, J4,5  =  7.8, 
J5,6  =  7.2  Hz, H-5Indol), 7.24–7.32 (m, 5H, H-3Indol, 
H-6Indol, 3HPh), 7.44 (d, 2H, J  =  7.2  Hz, 2HPh), 7.56 (d, 
1H, J6,7  =  8.4  Hz, H-7Indol), 7.64 (d, 1H, J4,5  =  7.8  Hz, 
H-4Indol); 13C NMR (DMSO-d6, 150  MHz) δ 25.2 CH2), 
35.0 (CH2Ph), 44.7 (CH2), 51.7 (CH2), 105.7 (C-3Indol), 
110.4 (C-7Indol), 120.3 (C-5Indol), 121.2 (C-4Indol), 123.3 
(C-6Indol), 126.5, 126.7, 127.2 (C-2Indol, C-3aIndol, CHPh), 
128.4 (2 CHPh), 128.9 (2 CHPh), 137.9, 137.6 (C-7aIndol, 
CPh), 148.6 (C-5Triazol), 158.5 (C-3Triazol); HRMS (EI) calcd 
for C20H18N4S (M+.): 346.1252. Found: 346.1243.
2,3‑Bis((3‑benzylsulfanyl‑5‑(1H‑indol‑2‑yl)‑1,2,4‑triazol‑1‑yl)
methyl)quinoxaline (11)
White solid, Yield 20 %; m.p. 175–176  °C; Rf 0.41 (ethyl 
acetate/n-hexane 3:7); 1H NMR (CDCl3, 300  MHz) δ 
4.34 (s, 4 H, 2 SCH2Ph), 6.14 (s, 4 H, 2 NCH2 quinoxalin), 
7.11–7.39 (m, 16 H, 2 H-3Indol, 2 H-5Indol, 2 H-6Indol, 10 
H, 2Ph), 7.57 (d, 2 H, J6,7 9.0 Hz, 2 H-4Indol), 7.76 (d, 2 H, 
J4,5 9.0 Hz, 2 H-7Indol), 7.87–7.91 (m, 2 H, 2 CHquinoxalin), 
8.15–8.18 (m, 2 H, 2 CHquinoxalin), 10.56 (s, 2 H, NHIndol); 
13C NMR (CDCl3, 100  MHz) δ 36.44 (2 CH2ph), 51.97 
(2 CH2 quinoxalin), 105.98 (2 C-3Indol), 111.80 (2 C-7Indol), 
120.96 (2 C-5Indol), 122.04 (2 C-4Indol), 122.04(2 C-2Indol), 
124.60 (2 C-6Indol), 127.41, 128.38, 128.52, 128.97, 129.01, 
131.77, 137.13, 137.24 (2 C-3aIndol, 10 CHph, 2CPh, 4 
CHquinoxalin, 2 C-7aIndol), 141.41, 149.05, 150.16, 160.33 
(2 Cquinoxalin, 2 C-3Triazol, 2 C-5Triazol); ESI+-MS m/z (rel. 
abundance  %): 119.7 (8), 148.9 (17), 301.0 (14), 360.2 (9), 
413.1 (8), 663.4 (6), 767.3 (28) (M + H)+ for C44H35N10S2, 
789.2 (45) (M + Na)+, 805.2 (100) (M + K)+.
2,3‑Bis((3‑benzylsulfanyl‑5‑(1H‑indol‑2‑yl)‑1,2,4‑triazol‑2‑yl)
methyl)quinoxaline (12)
White solid, Yield 50 %; m.p. 117–118  °C; Rf 0.65 (ethyl 
acetate/n-hexane 3:7); 1H NMR (DMSO-d6, 600 MHz) δ 
5.22 (s, 4 H, 2 SCH2-Ph), 5.42 (s, 4 H, 2 NCH2 quinoxalin), 
6.90 (s, 2 H, 2 H-3Indol), 6.97 (dd, 2 H, J4,5 7.8, J5,6 7.2, Hz, 
2 H-5Indol), 7.10 (dd, 2 H, J5,6 7.2, J6,7 7.8 Hz, 2 H-6Indol), 
7.21–7.26 (m, 10 H, 2Ph), 7.39 (d, 2 H, J6,7 8.1  Hz, 2 
H-4Indol), 7.46 (d, 2 H, J4,5 7.5  Hz, 2 H-7Indol), 7.82–7.34 
(m, 2 H, 2 CHquinoxalin), 7.99–8.01 (m, 2 H, 2 CHquinoxalin), 
11.60 (s, 2 H, NHIndol); 13C NMR (DMSO-d6, 150 MHz) 
δ 37.9 (2 CH2ph), 52.3 (2 CH2 quinoxalin), 101.5 (2C-3Indol), 
112.3 (2C-7Indol), 119.9 (2C-5Indol), 121.0 (2C-4Indol), 
122.72 (2C-6Indol), 127.66, 127.72, 127.74, 128.2, 128.4, 
128.75, 129.1, 129.4, 129.5, 130.9, 131.9, 136.1, 137.4 (2 
C-2Indol, 2 C-3aIndol, 10 CHph, 2CPh, 4 CHquinoxalin, 2 C-7aIn-
dol), 140.7, 151.4, 152.4, 156.8 (2 Cquinoxalin, 2 C-3Triazol, 2 
C-5Triazol); ESI+-MS m/z (rel. abundance  %): 148.9 (18), 
239.1 (7), 276.0 (27), 301.0 (20), 344.0 (12), 413.0 (11), 
540.1 (6), 633.5 (8), 767.2 (35) (M + H)+ for C44H35N10S2, 
789.2 (87) (M + Na)+, 805.2 (100) (M + K)+.
Table 5 AM1 calculations of triazole nitrogens, heat of formation and steric energy in 4-6
4 5 6
Charges (Mulliken charges): N(10) -0.0998 N(10) -0.0467 N(10) -0.1631
N(11) -0.1586 N(11) -0.1704 N(11) -0.0603
C(12) 0.0315 C(12) 0.0401 C(12) -0.0302
N(13) -0.1167 N(13) -0.1102 N(13) -0.1686
C(14) -0.2673 C(14) -0.2920 C(14) -0.1775
S(15) 0.3333 S(15) 0.2792 S(15) 0.3004
N(27) -0.1106 N(27) -0.1577 N(27) -0.1633
N(28) -0.1686 N(28) -0.0500 N(28) -0.0599
0.0487 C(29) C(29) -0.0363 C(29) -0.0302
N(30) -0.1025 N(30) -0.1138 N(30) -0.1690
C(31) -0.2605 C(31) -0.1921 C(31) -0.1773
S(32) 0.3425 S(32) 0.2906 S(32) 0.3002
Heat of formation (Kcal/Mol) 359.6466 356.9822 349.1808
Steric energy (Kcal/Mol) 37.7514 16.2704 85.3608
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